Atlas Trials

Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis

Clinical trial NCT02481453 · COMPLETED

Trial details

NCT number
NCT02481453
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Inclusion Body Myositis (IBM)
Start date
2015-07-15
Primary completion
2018-01-22
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.